• -50%

Cross Pharmaceuticals Izicol Junior 20 x 6gr for constipation

€20.00
€10.00 Save 50%
Tax included

Cross Pharmaceuticals Izicol Junior 20 x 6gr for constipation

FOR EFFECTIVE AND SAFE TREATMENT OF CONSTIPATION
Izicol JUNIOR is a medical device with macrogol 3350 in powder form, water-soluble, which aims to successfully treat constipation. Izicol JUNIOR has no flavor.

€20.00
€10.00 Save 50%
Tax included
Quantity

 
Security policy

(edit with the Customer Reassurance module)

 
Delivery policy

(edit with the Customer Reassurance module)

 
Return policy

(edit with the Customer Reassurance module)

Cross Pharmaceuticals Izicol Junior 20 x 6gr for constipation

FOR EFFECTIVE AND SAFE TREATMENT OF CONSTIPATION
Izicol JUNIOR is a medical device with macrogol 3350 in powder form, water-soluble, which aims to successfully treat constipation. Izicol JUNIOR has no flavor.

COMPOSITION AND USE

Macrogol 3350 is the only osmotic laxative with level of evidence 1 and grade of recommendation A, recommended for the treatment of constipation by the World Gastroenterology Organization. It is also recommended as a first line treatment for functional constipation, cases of “entrapment” in children, and as maintenance therapy.

  • Rapid laxative action
  • Worldwide recognized action
  • Suitable during pregnancy and breastfeeding
  • Safe
  • Suitable for long-term use
  • Does not affect the intestinal microflora, nor does disturb the electrolyte balance, and does not cause: gas, abdominal discomfort, painful bowel movements, urgent bowel movements, flatulence, and addiction
  • Rapid laxative action
  • Worldwide recognized action
  • Suitable during pregnancy and breastfeeding
  • Safe
  • Suitable for long-term use
  • Does not affect the intestinal microflora, nor does disturb the electrolyte balance, and does not cause: gas, abdominal discomfort, painful bowel movements, urgent bowel movements, flatulence, and addiction
1013001
New
91 Items

Specific References

EAN13
5214001323036
Comments (0)
No customer reviews for the moment.